Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy (original) (raw)

Role of the JAK/STAT signaling pathway in diabetic nephropathy

AJP: Renal Physiology, 2005

Enhanced Expression of JAK-STAT Pathway Members in Human Diabetic Nephropathy

2008

Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli

Farhad Amiri

Ajp: Renal Physiology, 2004

View PDFchevron_right

Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy

Berne Yee

Diabetes, 2008

View PDFchevron_right

SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition

Jesus Egido

Laboratory investigation; a journal of technical methods and pathology, 2018

View PDFchevron_right

Diabetes and Suppressors of Cytokine Signaling Proteins

Nils Billestrup

Diabetes, 2007

View PDFchevron_right

Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose

Farhad Amiri

Kidney International, 2002

View PDFchevron_right

Suppressors of Cytokine Signaling Regulate Angiotensin II-Activated Janus Kinase-Signal Transducers and Activators of Transcription Pathway in Renal Cells

Marta Ruiz-ortega

Journal of the American Society of Nephrology, 2005

View PDFchevron_right

Hyperglycemia Enhances Angiotensin II-induced Janus-activated Kinase/STAT Signaling in Vascular Smooth Muscle Cells

farhad amiri

Journal of Biological Chemistry, 1999

View PDFchevron_right

SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of β Cell Insulin Gene Transcription and Secretion in Response to Interferon-γ

Sandra Cottet

Journal of Biological Chemistry, 2001

View PDFchevron_right

New perspectives on markers implicated in signalling pathways that advance diabetic nephropathy and its therapeutic approaches

RAHUL SHARMA

International Journal of Basic & Clinical Pharmacology, 2025

View PDFchevron_right

SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of beta Cell Insulin Gene Transcription and Secretion in Response to Interferon-gamma

Philippe Dupraz

Journal of Biological Chemistry, 2001

View PDFchevron_right

Molecular signaling pathways of diabetic kidney disease; new concepts J Prev Epidemiol. 2017;2(2):e03 Review Journal of Preventive Epidemiology

Masoud Amiri

View PDFchevron_right

Molecular signaling pathways of diabetic kidney disease; new concepts

Masoud Amiri

2017

View PDFchevron_right

Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes

Antonello Pileggi

Kidney international, 2009

View PDFchevron_right

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ

Fátima Cano Cano

International Journal of Molecular Sciences

View PDFchevron_right

Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells

Amy Banes-Berceli

AJP: Renal Physiology, 2006

View PDFchevron_right

Inhibition of the JAK/STAT Signaling Pathway Prevents the High Glucose-Induced Increase in TGF- and Fibronectin Synthesis in Mesangial Cells

Farhad Amiri

Diabetes, 2002

View PDFchevron_right

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes

Alejandra Droguett

BMJ Open Diabetes Research & Care

View PDFchevron_right

Characterization of diabetic nephropathy in CaM kinase IIa (Thr286Asp) transgenic mice

Shin Takasawa

Biochem Biophys Res Commun, 2009

View PDFchevron_right

Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease

Brad Dieter

PLOS ONE, 2019

View PDFchevron_right

Suppressor of cytokine signaling 2 (SOCS2) deletion protects against multiple low dose streptozotocin-induced type 1 diabetes in adult male mice

amilcar morales

Hormone Molecular Biology and Clinical Investigation, 2016

View PDFchevron_right

Activation of Tubular Epithelial Cells in Diabetic Nephropathy

Michael Kasper

Diabetes, 2002

View PDFchevron_right

Characterization of diabetic nephropathy in CaM kinase IIα (Thr286Asp) transgenic mice

Shin Takasawa

Biochemical and Biophysical Research Communications, 2009

View PDFchevron_right

Renal Protective Effect of Boeravinone B against Diabetic Nephropathy Rats via Inhibition of The Inflammatory and JAK2/STAT3 Signalling Pathway

Cell Journal Yakhteh

Vol 26, No 6, June , 2024

View PDFchevron_right

Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism

Mandeep Arora

Journal of Cardiovascular Pharmacology, 2009

View PDFchevron_right

Target Cell Expression of Suppressor of Cytokine Signaling1 Prevents Diabetes in the NOD Mouse

deepak yadav

Diabetes, 2003

View PDFchevron_right

Transcription factors in the pathogenesis of diabetic nephropathy

Amber Jinx Carrie Castro Sanchez

Expert Reviews in Molecular Medicine, 2009

View PDFchevron_right

Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats

Eman Said

Chemico-biological interactions, 2018

View PDFchevron_right

Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rats

Y. Li

Nephrology Dialysis Transplantation, 2007

View PDFchevron_right

Overview: Combating Diabetic Nephropathy

Fuad Ziyadeh

Journal of the American Society of Nephrology, 2003

View PDFchevron_right

Progression of diabetic nephropathy

Daisuke Koya

American Journal of Kidney Diseases, 2003

View PDFchevron_right

Molecular Mechanisms of Diabetic Nephropathy , General Preventive Measures and Novel Therapeutic Strategies

Najia Sherzay

2018

View PDFchevron_right

Role of Inflammation in the Pathogenesis of Diabetic Nephropathy

International Journal of Diabetology and Vascular Disease Research (IJDVR)

View PDFchevron_right

Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy (original) (raw)

Related papers